Sinsin Pharmaceutical Co., Ltd (KOSDAQ: 002800)
South Korea
· Delayed Price · Currency is KRW 6,240.00
+90.00 (1.46%)
Oct 14, 2024, 2:15 PM KST
Sinsin Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | 4,049 | 4,680 | 4,415 | -1,476 | 362.66 | 2,138 | Upgrade
|
| Depreciation & Amortization | 4,142 | 3,937 | 3,758 | 3,672 | 2,584 | 1,171 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0 | -38.55 | -0.73 | -4,581 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 18.16 | - | 297.1 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.27 | Upgrade
|
| Provision & Write-off of Bad Debts | 41.27 | -30.85 | -159.25 | 1.26 | -86 | 596.92 | Upgrade
|
| Other Operating Activities | 2,224 | 2,366 | 1,531 | -344.75 | 190.08 | -827.08 | Upgrade
|
| Change in Accounts Receivable | -3,946 | -2,201 | -2,373 | -659.54 | 1,797 | 1,185 | Upgrade
|
| Change in Inventory | -1,747 | -3,022 | -5,062 | 1,316 | 1,422 | -3,447 | Upgrade
|
| Change in Accounts Payable | -1,815 | 241.53 | 2,063 | -2,165 | 840.24 | -1,202 | Upgrade
|
| Change in Other Net Operating Assets | 545.5 | -2,042 | 1,327 | -337.92 | -663.75 | -4,417 | Upgrade
|
| Operating Cash Flow | 3,454 | 3,930 | 5,461 | 23.18 | 1,865 | -4,506 | Upgrade
|
| Operating Cash Flow Growth | -61.64% | -28.03% | 23453.48% | -98.76% | - | - | Upgrade
|
| Capital Expenditures | -2,934 | -5,011 | -907.13 | -2,682 | -11,969 | -20,505 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 43.64 | 0.79 | 18,771 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -8.11 | -16.11 | -94.65 | - | 106.77 | - | Upgrade
|
| Investment in Securities | -1,004 | -1,004 | -176.61 | -3.41 | -2,790 | -3.4 | Upgrade
|
| Other Investing Activities | -46 | -20 | -10 | 33 | 4,511 | -54.45 | Upgrade
|
| Investing Cash Flow | -3,992 | -6,051 | -1,145 | -2,652 | 8,630 | -20,562 | Upgrade
|
| Short-Term Debt Issued | - | 25,306 | 18,349 | 20,224 | 21,676 | 17,263 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 3,000 | 8,763 | 21,788 | Upgrade
|
| Total Debt Issued | 30,477 | 25,306 | 18,349 | 23,224 | 30,439 | 39,051 | Upgrade
|
| Short-Term Debt Repaid | - | -20,958 | -19,275 | -17,421 | -26,510 | -12,602 | Upgrade
|
| Long-Term Debt Repaid | - | -3,434 | -1,899 | -4,914 | -12,591 | -1,658 | Upgrade
|
| Total Debt Repaid | -29,573 | -24,392 | -21,174 | -22,335 | -39,100 | -14,260 | Upgrade
|
| Net Debt Issued (Repaid) | 904.07 | 914.06 | -2,825 | 889.86 | -8,661 | 24,791 | Upgrade
|
| Dividends Paid | -910.23 | -758.53 | - | - | -424.77 | -500.63 | Upgrade
|
| Other Financing Activities | 70 | 70 | - | 35 | -0 | 30 | Upgrade
|
| Financing Cash Flow | 63.84 | 225.54 | -2,825 | 924.86 | -9,086 | 24,321 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.23 | 1.89 | -50.12 | -0.96 | -35.11 | -16.39 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | -0 | - | - | - | Upgrade
|
| Net Cash Flow | -471.94 | -1,894 | 1,441 | -1,705 | 1,374 | -763.9 | Upgrade
|
| Free Cash Flow | 519.87 | -1,081 | 4,553 | -2,659 | -10,104 | -25,010 | Upgrade
|
| Free Cash Flow Margin | 0.49% | -1.05% | 4.95% | -3.59% | -15.05% | -36.86% | Upgrade
|
| Free Cash Flow Per Share | 34.27 | -71.27 | 300.15 | -175.28 | -666.04 | -1648.61 | Upgrade
|
| Cash Interest Paid | 2,017 | 1,987 | 1,406 | 948.55 | 1,210 | 1,247 | Upgrade
|
| Cash Income Tax Paid | 181.1 | -747.52 | -396.26 | 1,650 | -131.56 | 550.19 | Upgrade
|
| Levered Free Cash Flow | -271.9 | -3,157 | 3,362 | -2,642 | -4,699 | -23,625 | Upgrade
|
| Unlevered Free Cash Flow | 998.27 | -1,946 | 4,288 | -2,040 | -4,141 | -23,471 | Upgrade
|
| Change in Net Working Capital | 3,988 | 4,609 | 1,860 | 2,190 | -7,744 | 5,593 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.